Sherlock Biosciences has arrayed a team of all-star academics and innovators in pursuit of next-gen molecular diagnostics. Among its nine co-founders are leading researchers in CRISPR, synthetic biology and genomics pulled from top institutions such as Massachusetts Institute of Technology (MIT), the Broad Institute and the Wyss Institute at Harvard University.